• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Trump announces travel ban on dozen countries

    Trump announces travel ban on dozen countries

    Innovent’s IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer

    Million-plus pilgrims begin Hajj under blazing sun

    Million-plus pilgrims begin Hajj under blazing sun

    Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma

    Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma

    POWERCHINA Advances Malaysia’s Clean Energy Goals on World Environment Day 2025

    POWERCHINA Advances Malaysia’s Clean Energy Goals on World Environment Day 2025

    Seoul Releases Global Tourism Campaign Featuring Star Chef Edward Lee

    Seoul Releases Global Tourism Campaign Featuring Star Chef Edward Lee

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    CrowdStrike Shares Dip Despite Strong Q1 Earnings Amid Soft Revenue Guidance

    Constellation Energy (CEG) Stock Surges 37% in May 2025 Amid Strong Earnings and Strategic Partnerships

    Dunamu and HYBE’s NFT Platform ‘Momentica’ to Cease Operations Amid Ongoing Losses

    Shein Shifts IPO Plans to Hong Kong After London Listing Stalls

    Kingsoft Reports 9% Revenue Growth in Q1 2025 with Solid Gains in Office Software and Gaming

    Chinese firms double down on tech: Xiaomi, Haier

    Xiaomi Posts Record Q1 Results with Revenue Surpassing RMB 100 Billion and Net Profit Breaking RMB 10 Billion

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Trump announces travel ban on dozen countries

    Trump announces travel ban on dozen countries

    Innovent’s IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer

    Million-plus pilgrims begin Hajj under blazing sun

    Million-plus pilgrims begin Hajj under blazing sun

    Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma

    Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma

    POWERCHINA Advances Malaysia’s Clean Energy Goals on World Environment Day 2025

    POWERCHINA Advances Malaysia’s Clean Energy Goals on World Environment Day 2025

    Seoul Releases Global Tourism Campaign Featuring Star Chef Edward Lee

    Seoul Releases Global Tourism Campaign Featuring Star Chef Edward Lee

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    CrowdStrike Shares Dip Despite Strong Q1 Earnings Amid Soft Revenue Guidance

    Constellation Energy (CEG) Stock Surges 37% in May 2025 Amid Strong Earnings and Strategic Partnerships

    Dunamu and HYBE’s NFT Platform ‘Momentica’ to Cease Operations Amid Ongoing Losses

    Shein Shifts IPO Plans to Hong Kong After London Listing Stalls

    Kingsoft Reports 9% Revenue Growth in Q1 2025 with Solid Gains in Office Software and Gaming

    Chinese firms double down on tech: Xiaomi, Haier

    Xiaomi Posts Record Q1 Results with Revenue Surpassing RMB 100 Billion and Net Profit Breaking RMB 10 Billion

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News PR Newswire

How is vocational education today forging the craftspeople of tomorrow?

PR Newswire by PR Newswire
3 June 2025
in PR Newswire
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

BEIJING, June 3, 2025 /PRNewswire/ — Finding Answers in China from China.org.cn:

As China’s economic structure continues to upgrade, the demand for new-type skilled workers is growing rapidly. Vocational education is gaining increasing social recognition. How is vocational education developing in China? Can it meet the needs of the times and cultivate high-caliber technical professionals?

In this episode, Sinologist Elsbeth van Paridon, also an editor at CICG Americas, travels to Jiangsu — one of China’s economic powerhouse provinces — to find the answers.

How is vocational education today forging the craftspeople of tomorrow?
https://youtu.be/nVBjLw1tXsk

 

Tags: prnewswire
PR Newswire

PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

Read More

Innovent’s IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer

5 June 2025
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma

Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma

5 June 2025
  • Trending
  • Comments
  • Latest

Power Talk | Cody OOH’s Hilda Cheung: Reinventing Hong Kong’s Moving Billboards for the AI Age

2 June 2025
Tunnel runs smoothly after takeover

Tunnel runs smoothly after takeover

31 May 2025
HKUST to research AI impact on business

HKUST to research AI impact on business

30 May 2025

Mixed responses to new tolls at Tai Lam Tunnel

2 June 2025
Trump announces travel ban on dozen countries

Trump announces travel ban on dozen countries

5 June 2025

Innovent’s IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer

5 June 2025
Million-plus pilgrims begin Hajj under blazing sun

Million-plus pilgrims begin Hajj under blazing sun

5 June 2025
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma

Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma

5 June 2025

Recent News

Trump announces travel ban on dozen countries

Trump announces travel ban on dozen countries

5 June 2025

Innovent’s IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer

5 June 2025
Million-plus pilgrims begin Hajj under blazing sun

Million-plus pilgrims begin Hajj under blazing sun

5 June 2025
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma

Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Renal Cell Carcinoma

5 June 2025
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com